UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2021 Earnings Conference Call May 4, 2021 8:30 AM ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse Jon Block - Stifel Nathan Rich - Goldman Sachs Balaji Prasad - Barclays Operator Good morning and welcome to the IDEXX Laboratories' First Quarter 2021 Earnings Conference Call. As a reminder, today’s conference is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 0-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (State or other ju ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2020 Earnings Conference Call February 2, 2021 8:30 AM ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President & Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Erin Wright - Credit Suisse Nathan Rich - Goldman Sachs Jon Block - Stifel Chris Schott - JPMorgan Operator Good morning and welcome to the IDEXX Laboratories' Fourth Quarter 2020 Earnings Conference Call. As a reminder, today’s conference ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Dela ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2020 Earnings Conference Call October 29, 2020 8:30 AM ET Company Participants Jay Mazelsky - President and CEO Brian McKeon - CFO John Ravis - Senior Director, IR Conference Call Participants Ryan Daniels - William Blair Erin Wright - Credit Suisse Michael Ryskin - Bank of America Jon Block - Stifel Nathan Rich - Goldman Sachs David Westenberg - Guggenheim Securities Operator Good Morning, and welcome to the IDEXX Laboratories Third Quarter 2020 Earnings Call. As a ...

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2020 Earnings Conference Call July 31, 2020 8:30 AM ET Company Participants Brian McKeon - Chief Financial Officer Jay Mazelsky - President and Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Nathan Rich - Goldman Sachs Jon Block - Stifel David Westenberg - Guggenheim Securities Andrew Cooper - Raymond James Operator Good morning and welcome to the IDEXX Laboratories Second Quarter 2020 Earnings Conference Call. As a reminder, t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) Delaware ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________. COMMISSION FILE NUMBER: 000-19271 IDEXX LABORATORIES, INC. (Exact name of registrant as specified in its charter) (State o ...